3323. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
作者: Harry J de Koning.;Rafael Meza.;Sylvia K Plevritis.;Kevin ten Haaf.;Vidit N Munshi.;Jihyoun Jeon.;Saadet Ayca Erdogan.;Chung Yin Kong.;Summer S Han.;Joost van Rosmalen.;Sung Eun Choi.;Paul F Pinsky.;Amy Berrington de Gonzalez.;Christine D Berg.;William C Black.;Martin C Tammemägi.;William D Hazelton.;Eric J Feuer.;Pamela M McMahon.
来源: Ann Intern Med. 2014年160卷5期311-20页
The optimum screening policy for lung cancer is unknown.
3325. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer.
3326. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
作者: Heidi D Nelson.;Miranda Pappas.;Bernadette Zakher.;Jennifer Priest Mitchell.;Leila Okinaka-Hu.;Rongwei Fu.
来源: Ann Intern Med. 2014年160卷4期255-66页
Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are associated with increased risks for breast, ovarian, and other types of cancer.
3327. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
3330. Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement.
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for glaucoma.
3331. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.
The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2013 on lipid management and treatment of all adults and children with chronic kidney disease (CKD). All forms of CKD are included (non-dialysis-dependent, dialysis-dependent, and kidney transplant recipients).
3337. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Linda L Humphrey.;Nick Fitterman.;Melissa Starkey.;Paul Shekelle.; .
来源: Ann Intern Med. 2013年159卷11期770-779页
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the treatment of anemia and iron deficiency in adult patients with heart disease.
3338. Treatment of anemia in patients with heart disease: a systematic review.
作者: Devan Kansagara.;Edward Dyer.;Honora Englander.;Rongwei Fu.;Michele Freeman.;David Kagen.
来源: Ann Intern Med. 2013年159卷11期746-757页
The benefits of anemia treatment in patients with heart disease are uncertain.
3339. Examination of links between herpes zoster incidence and childhood varicella vaccination.
作者: Craig M Hales.;Rafael Harpaz.;M Riduan Joesoef.;Stephanie R Bialek.
来源: Ann Intern Med. 2013年159卷11期739-45页
Introduction of a universal varicella vaccine program for U.S. children in 1996 sparked concern that less-frequent exposure to varicella would decrease external boosting of immunity to varicella zoster virus and thereby increase incidence of herpes zoster (HZ).
3340. Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study.
作者: Thomas A Dewland.;Eric Vittinghoff.;Mala C Mandyam.;Susan R Heckbert.;David S Siscovick.;Phyllis K Stein.;Bruce M Psaty.;Nona Sotoodehnia.;John S Gottdiener.;Gregory M Marcus.
来源: Ann Intern Med. 2013年159卷11期721-8页
Atrial fibrillation (AF) prediction models have unclear clinical utility given the absence of AF prevention therapies and the immutability of many risk factors. Premature atrial contractions (PACs) play a critical role in AF pathogenesis and may be modifiable.
|